相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis
Jian-bo Gai et al.
BIOSCIENCE REPORTS (2020)
UBE2C Overexpression Aggravates Patient Outcome by Promoting Estrogen-Dependent/Independent Cell Proliferation in Early Hormone Receptor-Positive and HER2-Negative Breast Cancer
Yu-Jin Kim et al.
FRONTIERS IN ONCOLOGY (2020)
NEDDylation negatively regulates ERRβ expression to promote breast cancer tumorigenesis and progression
Sanoj K. Naik et al.
CELL DEATH & DISEASE (2020)
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
R. Condorelli et al.
ANNALS OF ONCOLOGY (2019)
Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: a population-based health record linkage study protocol
Sarah J. Lord et al.
BMJ OPEN (2019)
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients
Janos T. Fekete et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
A Comprehensive Bioinformatics Analysis of UBE2C in Cancers
Hassan Dastsooz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
Fengzhi Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells
Qin Lu et al.
CANCER MEDICINE (2019)
Deubiquitination and stabilization of estrogen receptor α by ubiquitin-specific protease 7 promotes breast tumorigenesis
Xiaohong Xia et al.
CANCER LETTERS (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
New proteasome inhibitors in the treatment of multiple myeloma
Vania Tietsche de Moraes Hungria et al.
HEMATOLOGY TRANSFUSION AND CELL THERAPY (2019)
The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization
Lei Li et al.
ONCOGENE (2018)
Epigenetic mechanism of survivin dysregulation in human cancer
Hui Lyu et al.
SCIENCE CHINA-LIFE SCIENCES (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
Ubiquitin-like Protein Conjugation: Structures, Chemistry, and Mechanism
Laurent Cappadocia et al.
CHEMICAL REVIEWS (2018)
DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer
S. Hernandez-Perez et al.
ONCOGENE (2017)
USP9X regulates centrosome duplication and promotes breast carcinogenesis
Xin Li et al.
NATURE COMMUNICATIONS (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Ubiquitin-conjugating enzyme E2T (UBE2T) and denticleless protein homolog (DTL) are linked to poor outcome in breast and lung cancers
Javier Perez-Pena et al.
SCIENTIFIC REPORTS (2017)
The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data
Chao-hua Mo et al.
CANCER CELL INTERNATIONAL (2017)
The importance of regulatory ubiquitination in cancer and metastasis
L. H. Gallo et al.
CELL CYCLE (2017)
Survivin contributes to DNA repair by homologous recombination in breast cancer cells
Eloise Vequaud et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
A. S. Hamy et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction
Agostinho Lemos et al.
MEDICINAL RESEARCH REVIEWS (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients
Lorinc Pongor et al.
GENOME MEDICINE (2015)
USP9X Downregulation Renders Breast Cancer Cells Resistant to Tamoxifen
Hendrika M. Oosterkamp et al.
CANCER RESEARCH (2014)
The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models
Wei Wang et al.
NATURE COMMUNICATIONS (2014)
USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase
S. Giovinazzi et al.
CELL DEATH AND DIFFERENTIATION (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole
Akhilesh Rawat et al.
CELLULAR ONCOLOGY (2013)
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses
Pascal Jezequel et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2013)
It takes two to tango: Ubiquitin and SUMO in the DNA damage response
Serena Bologna et al.
Frontiers in Genetics (2013)
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
A. Psyrri et al.
ANNALS OF ONCOLOGY (2012)
MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
Chen Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
International network of cancer genome projects
Thomas J. Hudson et al.
NATURE (2010)
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
D. Loussouarn et al.
BRITISH JOURNAL OF CANCER (2009)
Ubiquitination and Downregulation of BRCA1 by Ubiquitin-Conjugating Enzyme E2T Overexpression in Human Breast Cancer Cells
Tomomi Ueki et al.
CANCER RESEARCH (2009)
DNA methylation inhibits p53-mediated survivin repression
N. H. Nabilsi et al.
ONCOGENE (2009)
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
Jessica Kao et al.
PLOS ONE (2009)
Posttranslational protein modifications - Current implications for cancer detection, prevention, and therapeutics
Karl E. Krueger et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
